Investing Profile

Daniel Lynch

InvestorVC
unknown at unknown
gv.com/team/dan-lynch/Boston, Massachusetts
Photo of Daniel Lynch, Unknown Ventures
Your Intro Paths to Daniel Lynch

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Daniel is a member of
Stromedix Inc. Network
267 CONNECTIONS
Wesleyan University Network
47 CONNECTIONS
Bristol Myers Squibb Network
27 CONNECTIONS

Find Daniel Lynch on

cb
Current Investing Position
Unknown Ventures
Investment Range
$250K - $50.0M
Sweet Spot
$25.0M
Investments On Record
4

Daniel Lynch is on these Sector & Stage Rankings

Daniel Lynch's Investments On Record (3)

CompanyStageDateRound SizeTotal Raised
Tome Biosciences
Series ADec 2023$210M
$210M
Co-investors: Jorge Conde (Andreessen Horowitz), Alan Crane (Polaris Partners), Jay Markowitz (ARCH Venture Partners)
Blueprint Medicines
Series BJan 2014$25M
$65M
Co-investors: Stephen Knight (F-Prime Capital Partners), Thilo Schroeder (Nextech Invest)
Sesen Bio
Series AMay 2012$20M
Series AMar 2010$35M
$55M
Co-investors: Noubar Afeyan (Flagship Pioneering), Cary Pfeffer (Third Rock Ventures), David Berry (Flagship Ventures)

Daniel Lynch's Experience

Finance Bristol Myers SquibbPresent
Chairman of the Board Bluebird BioPresent
Board Member Ember TherapeuticsPresent
Chairman of the Board BIND TherapeuticsPresent
Chairman Of The Board Stromedix Inc.Present
Executive Chairman Nimbus TherapeuticsPresent
Chairman Of The Board Blueprint MedicinesPresent
Chairman Of The Board Surface Oncology Inc.Present
Chairman of the Board SpringWorks TherapeuticsPresent
Chairman Of The Board Xilio Therapeutics, Inc.Present
CEO ImClone Systems, a wholly-owned subsidiary of Eli Lilly and CompanyPresent

Daniel Lynch's Education

Wesleyan University Bachelor of Arts (B.A.) Mathematics

Investors who invest with Daniel Lynch

Sign in with Google →

Scouts & Angels Affiliated With Daniel Lynch

Sign in with Google →